{
  "symbol": "AMGN",
  "period": "2022",
  "report_type": "YearlyIncomeStatement",
  "items": {
    "Tax Effect Of Unusual Items": 0.0,
    "Tax Rate For Calcs": 0.145,
    "Normalized EBITDA": 14801000000.0,
    "Total Unusual Items": 0.0,
    "Total Unusual Items Excluding Goodwill": 0.0,
    "Net Income From Continuing Operation Net Minority Interest": 6717000000.0,
    "Reconciled Depreciation": 4071000000.0,
    "Reconciled Cost Of Revenue": 8451000000.0,
    "EBITDA": 14801000000.0,
    "EBIT": 10730000000.0,
    "Net Interest Income": -2875000000.0,
    "Interest Expense": 2875000000.0,
    "Normalized Income": 6717000000.0,
    "Net Income From Continuing And Discontinued Operation": 6717000000.0,
    "Total Expenses": 20293000000.0,
    "Total Operating Income As Reported": 7897000000.0,
    "Diluted Average Shares": 538000000.0,
    "Basic Average Shares": 535000000.0,
    "Diluted EPS": 12.49,
    "Basic EPS": 12.56,
    "Diluted NI Availto Com Stockholders": 6717000000.0,
    "Net Income Common Stockholders": 6717000000.0,
    "Net Income": 6717000000.0,
    "Net Income Including Noncontrolling Interests": 6717000000.0,
    "Net Income Continuous Operations": 6717000000.0,
    "Tax Provision": 1138000000.0,
    "Pretax Income": 7855000000.0,
    "Other Income Expense": 2833000000.0,
    "Other Non Operating Income Expenses": 2833000000.0,
    "Special Income Charges": 0.0,
    "Net Non Operating Interest Income Expense": -2875000000.0,
    "Interest Expense Non Operating": 2875000000.0,
    "Operating Income": 7897000000.0,
    "Operating Expense": 11842000000.0,
    "Other Operating Expenses": 879000000.0,
    "Research And Development": 4784000000.0,
    "Selling General And Administration": 6179000000.0,
    "Gross Profit": 19739000000.0,
    "Cost Of Revenue": 8451000000.0,
    "Total Revenue": 28190000000.0,
    "Operating Revenue": 26910000000.0
  }
}